Simvastatin and downstream inhibitors circumvent constitutive and stromal cell-induced resistance to doxorubicin in IGHV unmutated CLL cells.
about
Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia.Prognostic relevance of oxidative stress measurement in chronic lymphocytic leukaemia.Single cell profiling of phospho-protein levels in chronic lymphocytic leukemia.ABCA1, apoA-I, and BTN3A1: A Legitimate Ménage à Trois in Dendritic Cells.
P2860
Simvastatin and downstream inhibitors circumvent constitutive and stromal cell-induced resistance to doxorubicin in IGHV unmutated CLL cells.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Simvastatin and downstream inh ...... n in IGHV unmutated CLL cells.
@ast
Simvastatin and downstream inh ...... n in IGHV unmutated CLL cells.
@en
type
label
Simvastatin and downstream inh ...... n in IGHV unmutated CLL cells.
@ast
Simvastatin and downstream inh ...... n in IGHV unmutated CLL cells.
@en
prefLabel
Simvastatin and downstream inh ...... n in IGHV unmutated CLL cells.
@ast
Simvastatin and downstream inh ...... n in IGHV unmutated CLL cells.
@en
P2093
P2860
P50
P356
P1433
P1476
Simvastatin and downstream inh ...... in in IGHV unmutated CLL cells
@en
P2093
Chiara Riganti
Ilaria Buondonno
Ivana Campia
Mario Boccadoro
Marta Robino
Micol Rigoni
Myriam Foglietta
Patrizia Sciancalepore
P2860
P304
29833-29846
P356
10.18632/ONCOTARGET.4006
P407
P577
2015-10-01T00:00:00Z